Free Trial

Blue Zone Wealth Advisors LLC Has $4.28 Million Position in Danaher Corporation $DHR

Danaher logo with Medical background

Key Points

  • Blue Zone Wealth Advisors LLC increased its stake in Danaher Corporation by 12.8%, now holding 21,683 shares valued at approximately $4.28 million.
  • Danaher reported earnings of $1.80 per share for the last quarter, which surpassed expectations, with revenues up 3.4% year-over-year, amounting to $5.94 billion.
  • The company recently declared a quarterly dividend of $0.32 per share, indicating an annualized yield of 0.6% and a payout ratio of 27.23%.
  • Five stocks to consider instead of Danaher.

Blue Zone Wealth Advisors LLC lifted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 12.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 21,683 shares of the conglomerate's stock after purchasing an additional 2,462 shares during the quarter. Blue Zone Wealth Advisors LLC's holdings in Danaher were worth $4,283,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. GHP Investment Advisors Inc. grew its holdings in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC increased its position in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Red Tortoise LLC increased its position in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock worth $30,000 after purchasing an additional 98 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher in the first quarter worth $31,000. Finally, Dunhill Financial LLC increased its position in shares of Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Insider Activity

In other Danaher news, Director Teri List sold 2,778 shares of the business's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 11.10% of the stock is currently owned by insiders.

Danaher Trading Down 1.0%

Shares of DHR stock opened at $202.53 on Friday. The company has a market cap of $145.02 billion, a P/E ratio of 43.09, a PEG ratio of 2.91 and a beta of 0.77. The stock has a 50 day simple moving average of $200.66 and a two-hundred day simple moving average of $197.25. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio (DPR) is 27.23%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on DHR shares. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Guggenheim reaffirmed a "buy" rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Redburn Partners set a $220.00 price objective on Danaher in a research note on Wednesday. Rothschild Redb lowered Danaher from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Finally, Rothschild & Co Redburn reiterated a "neutral" rating and issued a $220.00 target price (down from $245.00) on shares of Danaher in a research report on Wednesday. Seventeen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $244.60.

View Our Latest Stock Analysis on Danaher

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.